MTM1
Myotubularin
Also known as: MTM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13496
- Gene
- MTM1
- Ensembl
- ENSG00000171100
- Chromosome
- X
- Canonical length
- 603 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes a dual-specificity phosphatase that acts on both phosphotyrosine and phosphoserine. It is required for muscle cell differentiation and mutations in this gene have been identified as being responsible for X-linked myotubular myopathy. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
603 residues, UniProt reviewed canonical sequence.
>Q13496|MTM1
1 MASASTSKYN SHSLENESIK RTSRDGVNRD LTEAVPRLPG ETLITDKEVI YICPFNGPIK
61 GRVYITNYRL YLRSLETDSS LILDVPLGVI SRIEKMGGAT SRGENSYGLD ITCKDMRNLR
121 FALKQEGHSR RDMFEILTRY AFPLAHSLPL FAFLNEEKFN VDGWTVYNPV EEYRRQGLPN
181 HHWRITFINK CYELCDTYPA LLVVPYRASD DDLRRVATFR SRNRIPVLSW IHPENKTVIV
241 RCSQPLVGMS GKRNKDDEKY LDVIRETNKQ ISKLTIYDAR PSVNAVANKA TGGGYESDDA
301 YHNAELFFLD IHNIHVMRES LKKVKDIVYP NVEESHWLSS LESTHWLEHI KLVLTGAIQV
361 ADKVSSGKSS VLVHCSDGWD RTAQLTSLAM LMLDSFYRSI EGFEILVQKE WISFGHKFAS
421 RIGHGDKNHT DADRSPIFLQ FIDCVWQMSK QFPTAFEFNE QFLIIILDHL YSCRFGTFLF
481 NCESARERQK VTERTVSLWS LINSNKEKFK NPFYTKEINR VLYPVASMRH LELWVNYYIR
541 WNPRIKQQQP NPVEQRYMEL LALRDEYIKR LEELQLANSA KLSDPPTSPS SPSQMMPHVQ
601 THFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MTM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- liver: 17 nTPM
- rectum: 17 nTPM
- colon: 17 nTPM
- parathyroid gland: 14 nTPM
- kidney: 12 nTPM
- lymph node: 11 nTPM
Single-cell type
- sertoli cells: 190 nCPM
- neutrophil progenitors: 157 nCPM
- ependymal cells: 134 nCPM
- astrocytes: 119 nCPM
- adrenal cortex cells: 114 nCPM
- neutrophils: 114 nCPM
Immune cell
- eosinophil: 19 nTPM
- basophil: 18 nTPM
- T-reg: 11 nTPM
- NK-cell: 9.9 nTPM
- myeloid DC: 8.5 nTPM
- intermediate monocyte: 7.7 nTPM
Brain region
- hypothalamus: 11 nTPM
- cerebellum: 9.8 nTPM
- midbrain: 9.7 nTPM
- white matter: 9.6 nTPM
- thalamus: 9.5 nTPM
- basal ganglia: 8.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MTM1.
Disease | AllUniProt
Conditions MTM1 is implicated in, by any mechanism.
- Myopathy, centronuclear, X-linked (CNMX) MIM:310400
Disease | GeneticClinVar
269 pathogenic / likely-pathogenic of 934 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Severe X-linked myotubular myopathy
- Centronuclear myopathy
- MTM1-related disorder
- Nonpapillary renal cell carcinoma
- Thyroid cancer, nonmedullary, 1
Disease | ImmuneIEDB
Conditions an epitope on MTM1 was assayed in.
- collecting duct carcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.4
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagosome assembly
- endosome to lysosome transport
- intermediate filament organization
- mitochondrion distribution
- mitochondrion organization
- muscle cell cellular homeostasis
- negative regulation of autophagosome assembly
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- negative regulation of proteasomal ubiquitin-dependent protein catabolic process
- negative regulation of TOR signaling
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- phosphatidylinositol biosynthetic process
- phosphatidylinositol dephosphorylation
- positive regulation of skeletal muscle tissue growth
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein dephosphorylation
- protein transport
- skeletal muscle tissue growth
- TOR signaling
- regulation of vacuole organization
Molecular functions
- intermediate filament binding
- phosphatidylinositol binding
- phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity
- phosphatidylinositol-3-phosphate phosphatase activity
- phosphoprotein phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MTM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MTM1 as an antibody target. Whether an autoantibody or antibody against MTM1 could matter depends on whether native MTM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MTM1 is annotated at the cell surface, where native MTM1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MTM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...